The French pharmaceutical group Sanofi and Verily Life Sciences, a subsidiary of the American giant Google, today announced the creation of a common company focused on offering products and services to diabetes patients.
In a joint statement, the two partners explained that the new common subsidiary will be called undounde and that their mission is to "help people with diabetes fully live with health by developing global solutions that combine instruments, computer programs, medical and professional care programs to allowA simple and intelligent management of the disease. "
Verily will offer your experience in miniaturized electronic objects, in analytics, in the development of computer programs for the consumer, as well as that of Sanofi in diabetes treatments.
Onduo will be based in Cambridge, near Boston, in the northeast of the United States, and its executive responsible will be Joshua Riff, who until now was vice president for prevention and well -being in Optum, a health services company of the United Group.
Your business will focus on patients with type 2 diabetes, according to the description of your creators, in proposing solutions that help them make better decisions in their day to day. "That includes an improvement in the management of the management ofYour medication, but also in terms of habits and objectives.
In the longest term, the new subsidiary plans to expand its activity to patients with type 1 diabetes and, "eventually", to people at risk to develop diabetes with the aim of preventing.
